2 completed, 1 recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Recruiting 1 |
Follow REGN7508: new trials by email Literature Review of REGN7508 trials Research Report on REGN7508
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation REGN7508, REGN9933, Apixaban - Atrial Fibrillation (AF) | Phase 2 | Recruiting | Regeneron Pharmaceuticals | 1200 | 2025-10-20 | 2026-11-05 |
| A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adults Who Have a Peripherally Inserted Central Catheter (PICC) REGN9933, REGN7508, Placebo - Venous Thromboembolism | Phase 2 | Completed | Regeneron Pharmaceuticals | 195 | 2024-09-20 | 2026-04-13 |
| A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants REGN7508, Enoxaparin - Venous Thromboembolism | Phase 2 | Completed | Regeneron Pharmaceuticals | 179 | 2024-06-27 | 2026-05-27 |
Venous Thromboembolism (2) · Atrial Fibrillation (1) · Hemorrhage (1) · Stroke (1) · Thrombosis (1)
Bulgaria (2) · Canada (2) · United States (2) · Argentina (1) · Brazil (1) · Hungary (1) · Israel (1) · Latvia (1) · Lithuania (1) · Poland (1) · Romania (1) · United Kingdom (1)
2023 (2)